(Q79791286)
Statements
Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21 (English)
Gary M Clark
Denni M Zborowski
Pedro Santabarbara
Keyue Ding
Marlo Whitehead
Lesley Seymour
Frances A Shepherd
National Cancer Institute of Canada Clinical Trials Group